StockData
CytoMed Therapeutics Ltd logo

CytoMed Therapeutics Ltd (GDTC) stock

GDTCNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Mar 31, 2026Score 4/30
$0.83+0.05 (+6.00%)

Close on Nov 18, 2026Market cap $9.82MP/E –Yield –

CytoMed Therapeutics operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

For fiscal 2025 it was -3.70M SGD. The highest annual figure on record is -849.44K SGD in fiscal 2020.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-3.70M SGD–
FY2024Dec 31, 2024-2.71M SGD–
FY2023Dec 31, 2023-3.53M SGD–
FY2022Dec 31, 2022-1.40M SGD–
FY2021Dec 31, 2021-1.71M SGD–
FY2020Dec 31, 2020-849.44K SGD–

More CytoMed Therapeutics figures

See a number that looks wrong?